Researchers

eNauka >  Researchers >  Šušnjar, Snežana

Šušnjar, Snežana


Results 1-20 of 109
Issue DateTitleAuthor(s)TypeМp-cat.
2026Primary Uterine Nongestational Placental Site Trophoblastic Tumor as a Distinct EntityTrecourt, Alexis; Maher, Geoffrey J; Fisher, Rosemary A; Mcdonald, Katie; Seckl, Michael J; Winter, Matthew C; Susnjar, Snezana  ; Kesic, Vesna; Descargues, Pierre; Devouassoux-Shisheboran, Mojgan;
Allias, Fabienne; Kaur, Baljeet;
Article
21a+M21a+
2025Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial (vol 83, 104547, 2025)Demeestere, Isabelle; ...; Susnjar, Snezana V  ; ...; (broj, koautora 36)Other
Mp. category will be shown later
2025Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trialDemeestere, Isabelle; ...; Susnjar, Snezana V  ; ...; (broj, koautora 36)Article
21a+M21a+
2025Breastfeeding After Hormone Receptor-Positive Breast Cancer: Results From the POSITIVE TrialPeccatori, Fedro A; ...; Susnjar, Snezana  ; ...; (broj, koautora 35)Article
21a+M21a+
2025The Diagnostics of Disease Relapse Within Five-Year Follow-Up and the Role of Androgen Receptor Expression in Patients with Early Triple-Negative Breast CancerSpurnić, Igor  ; Šušnjar, Snežana  ; Jovanić, Irena; Medić-Milijić, Nataša; Milovanović, Zorka  ; Popović-Krneta, Marina  ; Bukumirić, Zoran  ; Gavrilović, Dušica; Rajšić, Saša; Marković, Ivan  Article
21M21
2024Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt PregnancyAzim, Jr Hatem A; ...; Susnjar, Snezana V  ; ...; (broj, koautora 36)Article
21a+M21a+
2023Interrupting Endocrine Therapy to Attempt Pregnancy after Breast CancerPartridge, Ann H; ...; Šušnjar, Snežana V  ; ...; (broj, koautora 39)Article
21a+M21a+
2023COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databasesMartin, P; Tsourti Z.; Ribiero J; ....; Šušnjar, S.  ; ......; (broj, koautora 25)Article
21aM21a
2023COVID-19 in cancer patients: Update from the joint analysis of ESMO-CoCARE, BSMO, PSMO international databasesMartin P.; ...; Šušnjar, Snežana V  ; ...; (broj, koautora 20)Article
21aM21a
2023Taxanes for the treatment of breast cancer during pregnancy: an international cohort studyGuajardo, Ana S Ferrigno; ...; Susnjar, Snezana V  ; ...; (broj, koautora 28)Article
21aM21a
2021COVID-19 and cancer: First report of the ESMO international, registry-based, cohort study (ESMO CoCARE)Romano, E; ...; Susnjar, Snezana V  ; ...; (broj, koautora 20)Conference Paper
Mp. category will be shown later
2021Histone Deacetylase 7 Gene Overexpression Is Associated with Poor Prognosis of Triple-Negative Breast Cancer PatientsUzelac, Bojana; Krivokuca, Ana M  ; Šušnjar, Snežana V  ; Milovanovic, Zorka M  ; Supic, Gordana M  Article
23M23
2021Patients with advanced cancer referred to a supportive care team (SCT) from a multidisciplinary tumor board (MTB): Symptom burden and its relationship with MTB treatment decisionĐorđevic, Feđa R; Čalamać, Marina; Bošnjak, Snežana M  ; Dimitrijevic, J; Zilic, Ana; Susnjar, Snezana V  ; Stankovic, Vesna  ; Lazin, N; Bakic, NConference Paper
Mp. category will be shown later
2021Clinical and pathological characteristics of male breast cancer at the Institute for Oncology including first-line treatment in hormone receptor positive tumoursŠerovic, Katarina; Jevric, Marko  ; Susnjar, Snezana V  ; Božovic-Spasojević, Ivana MConference Paper
34documentMNO za medicinske nauke (25.12.2024.)
M34
2020Expression of SIRT1, SIRT3 and SIRT6 Genes for Predicting Survival in Triple-Negative and Hormone Receptor-Positive Subtypes of Breast CancerUzelac Bojana; Krivokuća Ana  ; Branković-Magić Mirjana  ; Magić Zvonko  ; Šušnjar Snežana  ; Milovanović Zorka; Supić Gordana  Article
21M21
2019Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapyJevrić, Marko  ; Matić, Ivana  ; Krivokuća, Ana  ; Đorđić-Crnogorac, Marija  ; Besu-Žižak, Irina  ; Damjanović-Veličković, Ana  ; Branković-Magić, Mirjana  ; Milovanović, Zorka  ; Gavrilović, Dušica; Šušnjar, Snezana  ;
Kisić-Tepavčević, Darija  ; Stanojković, Tatjana  ;
Article
21M21
2019Importance of copy number alterations of FGFR1 and c-MYC genes in triple negative breast cancerNedeljković, Milica  ; Tanić, Nikola  ; Dramićanin, Tatjana  ; Milovanović, Zorka  ; Šušnjar, Snežana  ; Milinković, Vedrana; Vujović, Ivana; Prvanović, Mirjana  ; Dedović-Tanić, Nasta  Article
22M22
2019Difference in amplification of CCND1 oncogene in triple negative and hormone receptor positive breast cancerNedeljković, Milica D.  ; Nikola Tanić; Dramićanin, Tatjana S.  ; Zorka Milovanović  ; Snežana Šušnjar  ; Tanić, Nasta B.  Conference Paper
Mp. category will be shown later
2019The impact of PTEN inactivation on triple-negative breast cancer metastatic spread and prognosisNedeljković, Milica D.  ; Tanić, Nasta B.  ; Prvanović, Mirjana  ; Milovanović, Zorka  ; Šušnjar, Snežana  ; Tanić, Nikola  Conference Paper
Mp. category will be shown later
2018Real world data: Trastuzumab w/o concurrent endocrine therapy in luminal HER2-positive metastatic breast cancer resulted in decreased overall survivalŠusnjar, Snežana V  ; Popovic, Lazar S  ; Cvetanovic, Ana  ; Stanic, Nemanja S; Citic, J; Kolarov-Bjelobrk, Ivana N  ; Popovic, Marina  ; Nedovic, Nikola M; Stojanovic, Aleksandar; Matovina-Brko, Gorana;
Serović, Kristina; Milosavljevic, N; Mutrezani, Zafir; ...; Gavrilovic, Dusica; Radulovic, Sinisa S  ;
Conference Paper
34documentMNO za medicinske nauke (19.03.2025.)
M34